World Journal of Analytical Chemistry
ISSN (Print): 2333-1178 ISSN (Online): 2333-1283 Website: https://www.sciepub.com/journal/wjac Editor-in-chief: Raluca-Ioana Stefan-van Staden
Open Access
Journal Browser
Go
World Journal of Analytical Chemistry. 2014, 2(1), 6-9
DOI: 10.12691/wjac-2-1-2
Open AccessArticle

Identification and Quantitative Analysis of 2-Phenylethanol as Major Impurity in Bromadol by HPLC

Zhi Li1, , Ting Huang2, Jia-Hao Guo1 and Jing-Xiang Zhuang1

1Department of Chemistry, School of Science, Beijing Jiaotong University, Beijing, China

2Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing, China

Pub. Date: January 25, 2014

Cite this paper:
Zhi Li, Ting Huang, Jia-Hao Guo and Jing-Xiang Zhuang. Identification and Quantitative Analysis of 2-Phenylethanol as Major Impurity in Bromadol by HPLC. World Journal of Analytical Chemistry. 2014; 2(1):6-9. doi: 10.12691/wjac-2-1-2

Abstract

Bromadol can serve as a powerful and versatile agent in medicinal chemistry. In this paper, 2-phenylethanol was first identified as a main impurity in commercial Bromadol sample by HPLC. HPLC quantitative analysis method for impurity 2-phenylethanol in Bromadol has also been established for the first time. By our new HPLC analysis method, the impurity 2-phenylethanol was found to be 9.6% by weight. The identified main impurity 2-phenylethanol can be successfully removed by heating under vacuum, which gave an easy way to purify Bromadol for mass production.

Keywords:
HPLC Bromadol 2-phenylethanol

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Shetty, B. V.; Thomas, T. L. 1976, US Patent 4366172.
 
[2]  Lednicer, D.; Von Voigtlander, P. F. J. Med. Chem. 1979, 22, 1157-1158.
 
[3]  Liu, Z. H.; Jin, W. Q.; Dai, Q. Y.; Chen, X. J.; Zhang, H. P.; Chi, Z. Q. Life Sci, 2003, 73, 233-241.
 
[4]  Sundermann, B.; Hennies, H-h.; Englberger, W.; Wnendt, S. 2003, WO 2003008370.
 
[5]  Lednicer, D.; VonVoigtlander, P. F.; Emmert, D. E. J. Med. Chem, 1980, 23, 424-430.
 
[6]  Lednicer, D.; Von Voigtlander, P. F.; Emmert, D. E. J. Med. Chem. 1981, 24 341-346.
 
[7]  Lednicer, D.; VonVoigtlander, P. F.; Emmert, D. E. J. Med. Chem, 1981, 24, 404-408.
 
[8]  Sundermann, B.; Hennies, H-h.; Englberger, W.; Wnendt, S. 2007, US 7183436 B2.
 
[9]  Sundermann, B.; Hennies, H-h.; Englberger, W.; Koegel, B-Y. 2007, US7211694 B2.
 
[10]  VonVoigtlander, P. F.; Lednicer, D.; Lewis, R. A.; Gay, D. D. Proc. Int. Narc. Res. Club Conf. 1980, 17-21.
 
[11]  Rao, M. N. A.; Rao, S. C. Indian Drugs, 1985, 22, 252-257.
 
[12]  Lednicer, D. 1979, Patent: DE2839891. For the synthesis of compounds which have similar structure with Bromadol.
 
[13]  Zemolka, S.; Schunk, S.; Bergrath, E.; Kogel,B-Y.; Linz, K.; Schick, H.; Englberger, W. 2009, US2009/247505 A1.
 
[14]  Stefan P.; Carsten, G.; Wolfgang, H. 2013, US 2013/150590 A1.